FindTrial
Sign In

Use of a novel method of breast reconstruction after breast cancer surgery for improved function and appearance for patients operated at a tertiary care center

PROSPECTIVE STUDY ON THE USE OF LOCOREGIONAL PERFORATOR FLAPS IN POST MASTECTOMY BREAST RECONSTRUCTION IN A TERTIARY CARE CENTER - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084432
Enrollment
30
Registered
2025-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Perforator flap: Thoracodorsal artery perforator flap (TDAP), Lateral thoracic artery perforator flap (LTAP), Lateral intercostal artery perforator flap (LICAP) followed up for atleast

Sponsors

Dr Samyak Kucheria
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of breast cancer in the age group of 21-70 years who are planned to undergo reconstruction with locoregional perforator flap post mastectomy within 11 months from the date of approval from the Institutional Ethics Committee

Exclusion criteria

Exclusion criteria: Advanced Breast cancer patients with Stage 4 and/or metastatic disease.

Design outcomes

Primary

MeasureTime frame
The anatomical location (type) of perforator flap used for breast reconstructionTimepoint: 1 to 6 months—

Secondary

MeasureTime frame
Study the frequency of complications with the use of perforator flapsTimepoint: 1 to 6 months—

Countries

India

Contacts

Public ContactDr Samyak Kucheria

MGM Medical College, Indore

drmanishkaushal@gmail.com9425067722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026